SCHEMBL14554102

SCHEMBL14554102

Clc1nn2ccnc2c2c1CCCO2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8553896 0.78 HPGD (0.31) HPGDSMN1; SMN2
SCHEMBL14554042 0.71 PIM1 (0.30)
SCHEMBL14554107 0.69
SCHEMBL14554041 0.69
SCHEMBL22743635 0.64 ACHE (0.32) ACHE
SCHEMBL3021418 0.64 HPGD (0.33) HPGDSMN1; SMN2
SCHEMBL5571592 0.64 L3MBTL1 (0.36) SMN1; SMN2
SCHEMBL3291693 0.62 ACHE (0.33) ACHE
SCHEMBL8553172 0.62 PIK3CG (0.35) SMN1; SMN2
SCHEMBL10916033 0.62 SMPD3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013005041-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2013-01-10 WO disclosed